Effect of Traditional Chinese Medicine on the Cardiovascular Diseases

Abstract

Background: Traditional Chinese medicine (TCM) is the health care system developed with the help of clinical trials that are based ideally on the scientific model of regulation.Objective: This systematic health care system relies on some specific unique theories and practical experiences to treat and cure diseases, thus enhancing the public’s health.Review Methodology: The current review covers the available literature from 2000 to 2021. The data was collected from journals research articles, published books, thesis, and electronic databases, search engines such as Google Scholar, Elsevier, EBSCO, PMC, PubMed, ScienceDirect, Willey Online Library, Springer Link, and CNKI) searching key terms, cardiovascular disease, traditional Chinese medicines, natural products, and bioactive compounds. Full-length articles and abstracts were screened for the collection of information included in the paper.Results: Clinical trials on the TCM and basic research carried out on its mechanism and nature have led to the application and development of the perfect design of the research techniques, for example, twofold striking in acupuncture that aid in overcoming the limitations and resistances in integrating and applicability of these experiences and trials into the pre-existing biomedical models. Furthermore, TCM has also been utilized from ancient times to treat heart diseases in Asia, particularly in China, and is now used by people in many other areas. Cardiovascular disease (CVD) is mainly developed by oxidative stress. Hence antioxidants can be beneficial in treating this particular disease. TCM has a wide variety of antioxidant components.Conclusion: The current review article summarizes the underlying therapeutic property of TCM and its mechanism. It also overviews the evidence of the mechanism of TCM action in CVD prevention by controlling oxidative stress and its signaling pathway.

Advance Care Planning Engagement Among Family Members of Community-Dwelling Elderly Patients With Chronic Diseases in China

“…A total of 320 family members were selected, and 273 of them completed the survey. Inclusion criteria were as follows: (1) 18 years or older; (2) had a family member 60 years or older with at least 1 officially diagnosed chronic disease (the diagnosis of chronic diseases in this study included diabetes, cardiovascular and cerebrovascular diseases, cancer, respiratory diseases, digestive diseases, chronic kidney disease, and others) (Table 1) 20 ; (3) the main biological family caregivers of the patient; and (4) able to communicate. For the qualitative phase, the researchers selected participants with different characteristics and levels of ACP engagement based on quantitative data.…”

[Retracted] Identifying the Effect of Nuanxin Capsules on Myocardial Injury Induced by Chronic Hypoxia via Network Pharmacology Analysis and Experimental Validation

“…Traditional Chinese medicine contains multicompounds and exerts therapeutic effects on HF by targeting multiple targets through multiple pathways; it has been proven to be effective and safe in preventing and treating cardiovascular diseases in China [ 8 ]. The Nuanxin capsule (NX), an in-hospital preparation of Guangdong Provincial Hospital of Chinese Medicine prescribed by Professor Tietao Deng, has been used in clinical practice for 15 years and has a stable and safe effect in chronic HF [ 9 ].…”

Mechanism of Danggui Buxue decoction in the treatment of myocardial infarction based on network pharmacology and experimental identification

“…Treatment with creatine phosphate and ubidecarenone has short-term effects on improving the energy process in contraction, while beta-receptor blockers and calcium antagonists are used to relieve chronic coronary syndrome. Several studies have found that traditional Chinese medicine (TCM) has obvious advantages in the treatment of MI [ [3] , [4] , [5] ].…”